PhytoCeutica
PhytoCeutica is a privately-held New Haven biotech founded in 1999 that develops traditional Chinese medicine-derived compounds into FDA-approved prescription oncology drugs, currently operating with 1-10 employees and no disclosed commercial products.
- Company typePrivate
- Founded1999
- HeadquartersNew Haven, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
PhytoCeutica firmographics
Firmographics- Name
- PhytoCeutica
- Website
- https://phytoceutica.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- PhytoCeutica is a privately-held New Haven biotech founded in 1999 that develops traditional Chinese medicine-derived compounds into FDA-approved prescription oncology drugs, currently operating with 1-10 employees and no disclosed commercial products.
- Ownership category
- akta.pro rank
PhytoCeutica industry classification
Industry- Product category
- Oncology Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Oncology Specialty Pharmaceuticals (HLAIACAA)
Keywords
Where PhytoCeutica is headquartered
LocationHeadquarters
- HQ city
- New Haven
- HQ country
- United States
- HQ region
- North America
Markets served
PhytoCeutica business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations
PhytoCeutica product offering
Product offeringCore offering
PhytoCeutica develops traditional Chinese medicine (TCM) formulations into FDA-approved prescription drug candidates for the treatment of cancer. The company focuses on oncology therapeutics and currently operates as an early-stage research and development venture without disclosed commercial products.
Differentiator
Problem solved
Functional benefit
Products and services
- Traditional Chinese Medicine-based oncology drug candidates
Companies that use PhytoCeutica
Customer profileIdeal customer profiles1 record
PhytoCeutica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
PhytoCeutica partnerships and signals
Strategic signalScale indicators2 records
PhytoCeutica competitors and assessment
Company assessmentDirect peers
- Ascentage Pharma: Ascentage Pharma is a clinical-stage oncology company developing small molecules against apoptosis and protein homeostasis targets with global development ambitions; comparable as a focused oncology drug development platform.
- Athenex: Athenex developed plant-derived oncology therapies (including oral paclitaxel and tirbanibulin), pursuing FDA approval pathways for botanical-oncology assets at a far larger scale than PhytoCeutica.
- HUTCHMED (formerly Hutchison China MediTech): HUTCHMED discovers and develops TCM-derived oncology drugs (savolitinib, surufatinib, fruquintinib) and has multiple FDA approvals/NDA-stage assets. It is the closest direct comparable to PhytoCeutica's TCM-into-FDA-oncology mandate, with vastly greater scale.
- Jaguar Health: Jaguar Health is a plant-derived pharmaceutical company focused on oncology and gastrointestinal conditions (crofelemer, crofelemer-related oncology assets), directly comparable as a botanical-derived oncology drug developer.
Broad incumbents
- BeiGene: BeiGene is a global oncology biotech (Brukinsa, tislelizumab) with a deep oncology pipeline and FDA-approved assets, representing the broader incumbent scale against which PhytoCeutica would compete for talent and partnerships.
- Hengrui Medicine (Jiangsu Hengrui Pharmaceuticals): Hengrui is China's largest innovative pharma, with broad oncology and TCM-derived drug portfolios, offering a well-funded incumbent peer for evaluating TCM/synthetic oncology competitive dynamics.
Emerging players
- Innovent Biologics: Innovent Biologics is a China-based biopharma commercializing oncology biologics (PD-1, biosimilars) with partial overlap to PhytoCeutica's TCM-rooted oncology ambitions through oncology market participation.
Regional players
- Luye Pharma Group: Luye Pharma develops oncology and central nervous system drugs with significant TCM-derived oncology presence in China; comparable as a regional oncology peer focused on TCM-modality assets outside the US FDA pathway.
Market position
Customer concentration
PhytoCeutica social profiles
Digital presencePhytoCeutica financial estimates
Financial estimateRevenue estimate
Valuation estimate
PhytoCeutica leadership team
Management profileNumber of profiles
Profiles5 records
PhytoCeutica funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PhytoCeutica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PhytoCeutica
What does PhytoCeutica do?
PhytoCeutica develops traditional Chinese medicine (TCM) formulations into FDA-approved prescription drug candidates for the treatment of cancer. The company focuses on oncology therapeutics and currently operates as an early-stage research and development venture without disclosed commercial products.
Is PhytoCeutica a public or private company?
PhytoCeutica is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PhytoCeutica founded?
PhytoCeutica was founded in 1999. It employs 1 to 10 people.
Where is PhytoCeutica based?
PhytoCeutica is headquartered in New Haven, United States, in the North America region.
Who are PhytoCeutica's main competitors?
Direct peers on record are Ascentage Pharma, Athenex, HUTCHMED (formerly Hutchison China MediTech) and Jaguar Health. Broad incumbents are BeiGene and Hengrui Medicine (Jiangsu Hengrui Pharmaceuticals). Innovent Biologics is listed as an emerging player. Luye Pharma Group is listed as a regional player.
Does PhytoCeutica have an API?
No public API is recorded for PhytoCeutica.
What industry is PhytoCeutica in?
PhytoCeutica's product category is Oncology Pharmaceuticals. Its primary akta.pro industry code is HLAIACAA, Oncology Specialty Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.